查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1873979

成瘾治疗市场

Addictions Therapeutics Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024年，成瘾治疗市场规模估计为91.4亿美元，预计到2031年将达到144.9亿美元，2031年至2031年的复合年增长率为7.3%。各种治疗方法的不断推出预计将成为成瘾治疗市场的重要趋势。

成瘾治疗市场分析

各国领导人、监管机构和非政府组织正积极寻求创新方法，以提高公众对日益严重的药物成瘾问题的认识并应对这一问题。例如，化学品滥用委员会参与了多项州级和国家级倡议，旨在提高公众对药物滥用、康復和预防的认识。

联合国毒品和犯罪问题办公室（毒品和犯罪问题办公室）主导全球运动，旨在强调非法毒品，特别是青少年毒品问题，对社会带来的重大挑战。毒品和犯罪议题办公室在全球各地进行各种宣传活动，并鼓励个人、私部门、非营利组织和成员国实施打击毒品贩运和滥用的宣传方案。

此外，2023年8月，印度发起了一项旨在阻止青少年吸电子烟的运动。该运动旨在提出有效的解决方案，并寻求专家协助，以製定关于电子烟危害的有力宣传讯息。它还试图向公众介绍印度和其他国家对电子烟的禁令，并解释这些法规背后的原因。

此类旨在打击药物滥用和推广各种成瘾治疗的宣传活动和政府行动，可能会在预测期内推动市场成长。

成瘾治疗市场概览

全球成瘾治疗市场按地区划分为北美、欧洲、亚太、中东和非洲以及南美和中美洲。北美占据最大的市场份额，而亚太地区则是成长最快的地区。北美市场的成长主要归功于新市场参与者的涌入、众多产品的上市以及成瘾人数的增加。此外，亚太地区的成瘾治疗市场也正经历快速成长，其中中国、印度和日本是主要贡献者，这得益于高浓度的毒品消费、成瘾治疗仿製药的广泛研发以及本土企业的崛起。此外，跨国製药公司对研发的投入也推动了市场成长。

战略洞察

成瘾治疗市场的驱动因素与机会

加强组织间合作以促进市场成长

成瘾治疗市场中的许多机构正在建立合作关係，以促进市场成长。例如，2023年9月，Click Therapeutics与Indivior合作，共同开发和商业化处方数位疗法，旨在治疗物质使用障碍，首先从阿片类药物使用障碍（OUD）入手。此次合作将利用一款名为CT-102的行动应用程序，该程序旨在弥补OUD治疗中的重大缺口，例如提供高品质、个人化的心理社会支持。

同样，2023年1月，Pear Therapeutics扩大了与门诊戒瘾治疗诊所的合作。 Spero Health目前已能够在五个州的99个地点使用Pear的reSET和reSET-O处方数位疗法，而此前仅在肯塔基州的14家诊所使用。因此，各机构之间日益增加的合作正在推动戒瘾治疗市场的成长。

合约机构对研发的需求日益增长——这是一个市场机会

近年来，受多种因素推动，製药业的外包服务激增，这些因素包括止痛药需求不断增长、活性药物成分（API）日益复杂以及降低研发成本的需要。大型製药公司正透过外包研发活动来加速药物开发，同时降低成本。

许多製药公司，包括那些生产成瘾治疗药物的公司，都依赖合约研究组织 (CRO) 来降低内部研发和生产相关的高昂固定成本。新分子实体 (NME) 研发的日益复杂化，催生了对专业能力的需求，而企业更倾向于外包而非内部管理这些能力。随着药物获准数量的增加（FDA 在 2023 年批准了 55 种 NME），对强大的临床开发和外包服务的需求也日益增长。多家生物技术公司正在利用 CRO 来增强其候选药物管线。透过外包降低药物生产成本，预计将为市场参与者带来巨大的成长机会，使他们能够最大限度地提高利润率，并在不断发展的成瘾治疗药物市场中保持竞争力。

成瘾治疗市场細項分析

对成瘾治疗市场进行分析的关键细分市场包括治疗类型、药物类型、治疗中心和配销通路。

  • 依治疗类型划分，成瘾治疗市场可分为尼古丁成瘾治疗、酒精成瘾治疗、鸦片类药物成瘾治疗和其他物质成瘾治疗。 2023年，尼古丁成瘾治疗市占率最大。
  • 依药物类型划分，市场可分为伐尼克兰、安非他酮、尼古丁替代疗法产品、丁丙诺啡、纳曲酮、双硫崙和其他药物。 2023年，伐尼克兰占据了最大的市场份额。
  • 就治疗中心而言，市场分为门诊治疗中心、住宿治疗中心和住院治疗中心。 2023年，门诊治疗中心占据市场主导地位。

成瘾治疗市场地理分析

成瘾治疗市场报告的地理范围主要分为五个地区：北美、亚太、欧洲、中东和非洲以及南美/南美和中美洲。

北美是成瘾治疗领域的主要市场，其中美国市场份额最大，其次是加拿大。北美市场的成长特点是新市场参与者的涌入、各种产品的推出以及药物成瘾人数的不断增加。美国市场参与者正在筹集资金用于成瘾治疗。例如，2023年7月，致力于透过数位科技创新成瘾治疗的Affect Therapeutics公司宣布，已完成由专注于科技生物领域的投资公司ARTIS Ventures领投的A轮融资，金额达1,600万美元。这笔资金将用于拓展公司在全美范围内的项目，并透过技术改进提升Affect应用程式的效能。

成瘾治疗市场报告范围

成瘾治疗市场最新动态及新闻

成瘾治疗市场评估是透过收集定性和定量资料进行的，数据来源包括一手和二手研究，例如重要的企业出版物、协会资料和资料库。以下是成瘾治疗市场的一些最新发展：

  • 2023年1月，Hikma Pharmaceuticals PLC推出了预充式註射器（PFS）形式的盐酸纳洛酮注射（USP，2mg/2mL）。该药物用于紧急治疗已知或疑似阿片类药物过量，是该公司推出的第三款PFS产品。该注射液目前已在美国上市。 （资料来源：Hikma Pharmaceuticals PLC，2023）
  • 2022年1月，辉瑞与瑞典新创公司Alex Therapeutics合作，进军数位疗法市场。 Alex Therapeutics的AI驱动平台将认知行为疗法（CBT）和接受与承诺疗法（ACT）与人工智慧相结合，以实现个人化治疗。双方的合作初期专注于开发用于治疗尼古丁成瘾的数位疗法，首先在德国市场展开。 （图片来源：辉瑞，2022）

成瘾治疗市场报告的覆盖范围和交付成果

这份题为《成瘾治疗市场规模及预测（2022-2030）》的报告对市场进行了全面分析，涵盖以下领域：

  • 涵盖范围内所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态，例如驱动因素、限制因素和关键机会
  • 未来主要趋势
  • 详细的PEST/波特五力模型与SWOT分析
  • 全球及区域市场分析，涵盖关键趋势、主要参与者、法规及最新发展
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展动态
  • 公司详细概况

目录

第一章：引言

第二章：成瘾治疗市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：成瘾治疗市场及市场格局

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲和PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析

第五章：成瘾治疗市场及主要市场动态

  • 市场驱动因素
    • 一般人群中成瘾问题日益严重
    • 进行宣传活动
  • 市场约束
    • 药物研发成本不断攀升
  • 市场机会
    • 合约组织对研发的需求日益增长
  • 未来趋势
    • 持续推出治疗药物
  • 影响分析

第六章：成瘾治疗市场及全球分析

  • 全球成瘾治疗市场收入预测与分析
  • 全球成瘾治疗市场（按地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：成瘾治疗市场与治疗类型

  • 概述
  • 成瘾治疗市场占有率、治疗类型，2024 年及 2031 年（%）
  • 尼古丁成瘾治疗
    • 概述
      • 尼古丁成瘾治疗：成瘾治疗市场及收入预测（至2031年）
  • 酒精成瘾治疗
    • 概述
      • 酒精成瘾治疗：成瘾治疗市场及收入预测（至2031年）
  • 阿片类药物成瘾治疗
    • 概述
      • 阿片类药物成瘾治疗：成瘾治疗市场及收入预测（至2031年）
  • 其他物质成瘾治疗
    • 概述
    • 其他物质成瘾治疗：成瘾治疗市场及收入预测（至2031年）

第八章：成瘾治疗市场与药物类型

  • 概述
  • 成瘾治疗药物市场占有率（按药物类型划分），2024 年和 2031 年（%）
  • 伐尼克兰
    • 概述
      • 伐尼克兰：成瘾治疗市场及收入预测（至2031年）
  • 安非他酮
    • 概述
      • 安非他酮：成瘾治疗市场及收入预测（至2031年）
  • 尼古丁替代产品
    • 概述
      • 尼古丁替代疗法产品：成瘾治疗市场及收入预测（至2031年）
  • 丁丙诺啡
    • 概述
      • 丁丙诺啡：成瘾治疗市场及收入预测（至2031年）
  • 纳曲酮
    • 概述
      • 纳曲酮：成瘾治疗市场及收入预测（至2031年）
  • 双硫崙
    • 概述
      • 双硫崙：成瘾治疗市场及收入预测（至2031年）
  • 其他的
    • 概述
      • 其他：成瘾治疗市场及收入预测（至2031年）

第九章：成瘾治疗市集与治疗中心

  • 概述
  • 成瘾治疗市场份额，治疗中心，2024 年和 2031 年（%）
  • 门诊治疗中心
    • 概述
      • 门诊治疗中心：成瘾治疗市场及收入预测（至2031年）
  • 住宅治疗中心
    • 概述
      • 住宅治疗中心：成瘾治疗市场及收入预测（至2031年）
  • 住院治疗中心
    • 概述
      • 住院治疗中心：成瘾治疗市场及收入预测（至2031年）

第十章：成瘾治疗市场配销通路

  • 概述
  • 成瘾治疗市场占有率、配销通路，2024 年及 2031 年（%）
  • 医院药房
    • 概述
      • 医院药局：成瘾治疗市场及收入预测（至2031年）
  • 医疗用品商店
    • 概述
      • 医疗用品商店：成瘾治疗市场及收入预测（至2031年）
  • 其他的
    • 概述
      • 其他：成瘾治疗市场及收入预测（至2031年）

第十一章：成瘾治疗市场分析及至2031年预测与地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十二章：新冠疫情对全球成瘾治疗市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 世界其他地区

第十三章：成瘾治疗市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十四章：公司简介

  • Indivior PLC
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Orexo AB
  • Purdue Pharma L.P.
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC

第十五章：附录

简介目录
Product Code: TIPRE00015265

The size of the Addictions Therapeutics Market was estimated at US$ 9.14 billion in 2024 and is projected to reach US$ 14.49 billion by 2031, reflecting a CAGR of 7.3% through 2031 - 2031. The ongoing introduction of various therapeutics is anticipated to be a significant trend in the Addictions Therapeutics Market.

Analysis of the Addictions Therapeutics Market

Leaders, regulatory bodies, and NGOs are actively seeking innovative methods to raise awareness and combat the escalating issue of substance addiction. For example, the Council on Chemical Abuse engages in numerous state and national initiatives aimed at increasing awareness about substance misuse, recovery, and prevention.

The United Nations Office on Drugs and Crime (UNODC) spearheads a global campaign to highlight the significant societal challenges posed by illicit drugs, particularly among youth. The UNODC conducts various awareness initiatives worldwide and encourages individuals, the private sector, non-profit organizations, and member states to implement outreach programs against drug trafficking and abuse.

Additionally, in August 2023, a campaign was initiated in India to deter adolescents from vaping. This campaign aimed to propose effective solutions and enlisted expert assistance to develop impactful messaging about the harmful effects of vaping. It also sought to inform the public about the vaping ban in India and other nations, explaining the rationale behind such regulations.

Such awareness initiatives and governmental actions aimed at combating drug abuse and promoting treatments for various addictions are likely to drive market growth during the forecast period.

Overview of the Addictions Therapeutics Market

The global addictions therapeutics market is categorized by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America commands the largest market share, while the Asia Pacific region is the fastest-growing area. The growth in North America is primarily attributed to the entry of new market players, numerous product launches, and an increasing number of individuals with one or more substance addictions. Furthermore, the Asia Pacific region is experiencing rapid growth in addiction therapeutics, with China, India, and Japan being key contributors due to high narcotic consumption, extensive development of generic drugs for addiction treatment, and the rise of local companies. Additionally, investments in research and development (R&D) by multinational pharmaceutical firms are also propelling market growth.

Strategic Insights

Drivers and Opportunities in the Addictions Therapeutics Market

Increasing Collaborations Among Organizations to Boost Market Growth

Numerous organizations within the addictions therapeutics market are forming partnerships that enhance market growth. For instance, in September 2023, Click Therapeutics partnered with Indivior to develop and commercialize prescription digital therapeutics aimed at treating substance use disorders, beginning with Opioid Use Disorder (OUD). This collaboration will utilize a mobile application named CT-102, designed to fill significant gaps in OUD treatment, such as providing access to high-quality, personalized psychosocial support.

Similarly, in January 2023, Pear Therapeutics expanded its collaboration with outpatient addiction treatment clinics. Spero Health is now able to utilize Pear's reSET and reSET-O prescription digital therapeutics across 99 locations in five states, up from just 14 clinics in Kentucky. Thus, the increasing partnerships among organizations are driving the growth of the addictions therapeutics market.

Growing Demand for R&D from Contract Organizations - A Market Opportunity

In recent years, the pharmaceutical sector has seen a surge in outsourcing services, driven by factors such as the rising demand for pain medications, increased complexity of active pharmaceutical ingredients (APIs), and the need to lower development costs. Major pharmaceutical companies are outsourcing R&D activities to accelerate drug development while also reducing their costs.

Many pharmaceutical companies, including those producing addiction therapeutics, depend on contract research organizations (CROs) to lower the high fixed costs associated with in-house development and manufacturing. The growing complexity in developing new molecular entities (NMEs) has created a demand for specialized capabilities that companies prefer to outsource rather than manage internally. With an increase in drug approvals (the FDA approved 55 NMEs in 2023), there is a heightened demand for robust clinical development and outsourcing. Various biotechnology firms are leveraging CROs to enhance their drug candidate pipelines. The cost reductions in drug manufacturing through outsourcing are expected to present significant growth opportunities for market players, enabling them to maximize profit margins and remain competitive in the evolving addictions therapeutics market.

Segmentation Analysis of the Addictions Therapeutics Market

Key segments contributing to the analysis of the addictions therapeutics market include treatment type, drug type, treatment center, and distribution channel.

  • By treatment type, the addictions therapeutics market is divided into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and treatment for other substance addictions. The nicotine addiction treatment segment held the largest market share in 2023.
  • In terms of drug type, the market is categorized into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment accounted for the largest market share in 2023.
  • Regarding treatment centers, the market is segmented into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. The outpatient treatment center segment led the market in 2023.

Geographical Analysis of the Addictions Therapeutics Market

The geographical scope of the addictions therapeutics market report is primarily divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America is the leading market for addiction therapeutics, with the US holding the largest market share, followed by Canada. The growth in North America is characterized by the entry of new market players, various product launches, and an increasing number of individuals with substance addictions. Market participants in the US are raising funds for addiction treatment. For example, in July 2023, Affect Therapeutics, a company innovating addiction treatment through digital technology, announced it raised US$16 million in a Series A funding round led by ARTIS Ventures, a TechBio-focused investment firm. The funds will be utilized to expand the company's programs nationally and enhance the Affect app through engineering advancements.

Scope of the Addictions Therapeutics Market Report

Recent Developments and News in the Addictions Therapeutics Market

The addictions therapeutics market is assessed by collecting both qualitative and quantitative data through primary and secondary research, which includes significant corporate publications, association data, and databases. Below are some recent developments in the addictions therapeutics market:

  • In January 2023, Hikma Pharmaceuticals PLC launched Naloxone Hydrochloride Injection, USP, 2mg/2mL, in prefilled syringe (PFS) form. This medication is intended for the emergency treatment of known or suspected opioid overdoses and is the third PFS product introduced. The injection is currently available in the US. (Source: Hikma Pharmaceuticals PLC, 2023)
  • In January 2022, Pfizer partnered with Swedish start-up Alex Therapeutics to enter the digital therapeutics market. Alex Therapeutics' AI-driven platform combines cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI to tailor care. Their partnership initially focuses on developing digital therapeutics for nicotine addiction treatment, starting in the German market. (Source: Pfizer, 2022)

Coverage and Deliverables of the Addictions Therapeutics Market Report

The report titled "Addictions Therapeutics Market Size and Forecast (2022-2030)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Addictions Therapeutics Market and By Treatment Type
    • 1.3.2 Addictions Therapeutics Market and By Drug Type
    • 1.3.3 Addictions Therapeutics Market and By Treatment Center
    • 1.3.4 Addictions Therapeutics Market and By Distribution Channel
    • 1.3.5 Global Addictions Therapeutics Market and By Geography

2. Addictions Therapeutics Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Addiction Therapeutics Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia-Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA)and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis

5. Addiction Therapeutics Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Addiction Among General Populace
    • 5.1.2 Conduction of Awareness Campaigns
  • 5.2 Market Restraint
    • 5.2.1 Steeping Costs of Drug Development
  • 5.3 Market Opportunity
    • 5.3.1 Rising Demand for R and D from Contract Organizations
  • 5.4 Future Trend
    • 5.4.1 Consistent Launch of Therapeutics
  • 5.5 Impact Analysis

6. Addiction Therapeutics Market and Global Analysis

  • 6.1 Global Addictions Therapeutics Marker Revenue Forecast and Analysis
  • 6.2 Global Addictions Therapeutics Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Addictions Therapeutics Marketand Treatment Type

  • 7.1 Overview
  • 7.2 Addictions Therapeutics Market Share, Treatment Type, 2024 and 2031 (%)
  • 7.3 Nicotine Addiction Treatment
    • 7.3.1 Overview
      • 7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.4 Alcohol Addiction Treatment
    • 7.4.1 Overview
      • 7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.5 Opioid Addiction Treatment
    • 7.5.1 Overview
      • 7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.6 Other Substance Addiction Treatment
    • 7.6.1 Overview
    • 7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

8. Addictions Therapeutics Marketand Drug Type

  • 8.1 Overview
  • 8.2 Addictions Therapeutics Market Share, Drug Type, 2024 and 2031 (%)
  • 8.3 Varenicline
    • 8.3.1 Overview
      • 8.3.1.1 Varenicline: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.4 Bupropion
    • 8.4.1 Overview
      • 8.4.1.1 Bupropion: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.5 Nicotine Replacement Products
    • 8.5.1 Overview
      • 8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.6 Buprenorphine
    • 8.6.1 Overview
      • 8.6.1.1 Buprenorphine: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.7 Naltrexone
    • 8.7.1 Overview
      • 8.7.1.1 Naltrexone: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.8 Disulfiram
    • 8.8.1 Overview
      • 8.8.1.1 Disulfiram: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 8.9 Others
    • 8.9.1 Overview
      • 8.9.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

9. Addictions Therapeutics Marketand Treatment Center

  • 9.1 Overview
  • 9.2 Addictions Therapeutics Market Share, Treatment Center, 2024 and 2031 (%)
  • 9.3 Outpatient Treatment Center
    • 9.3.1 Overview
      • 9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 9.4 Residential Treatment Center
    • 9.4.1 Overview
      • 9.4.1.1 Residential Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 9.5 Inpatient Treatment Center
    • 9.5.1 Overview
      • 9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

10. Addictions Therapeutics Marketand Distribution Channel

  • 10.1 Overview
  • 10.2 Addictions Therapeutics Market Share, Distribution Channel, 2024 and 2031 (%)
  • 10.3 Hospital Pharmacies
    • 10.3.1 Overview
      • 10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 10.4 Medical Stores
    • 10.4.1 Overview
      • 10.4.1.1 Medical Stores: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)
  • 10.5 Others
    • 10.5.1 Overview
      • 10.5.1.1 Others: Addictions Therapeutics Marketand Revenue and Forecast to 2031 (US$ million)

11. Addiction Therapeutics Market Analysis and Forecasts To 2031 and Geographical Analysis

  • 11.1 North America: Addiction Therapeutics Market
    • 11.1.1 Overview
    • 11.1.2 North America: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
    • 11.1.3 North America: Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.1.4 North America: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
    • 11.1.5 North America: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.1.6 North America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.7 North America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.1.8 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.1 US: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.2 US: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.3 US: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.4 US: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.8.5 US: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.9 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.1 Canada: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.2 Canada: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.3 Canada: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.4 Canada: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.9.5 Canada: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.1.10 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.1 Mexico: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.2 Mexico: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.3 Mexico: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.4 Mexico: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.1.10.5 Mexico: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.2 Europe: Addiction Therapeutics Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Addiction Therapeutics Market, - Revenue and Forecast to 2031 (USD Million)
    • 11.2.3 Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
    • 11.2.4 Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.4.1 Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.2.5 Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.6 Europe: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.2.7 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.1 Germany: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.2 Germany: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.3 Germany: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.4 Germany: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.7.5 Germany: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.8 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.1 UK: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.2 UK: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.3 UK: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.4 UK: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.8.5 UK: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.9 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.1 France: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.2 France: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.3 France: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.4 France: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.9.5 France: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.10 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.1 Italy: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.2 Italy: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.3 Italy: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.4 Italy: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.10.5 Italy: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.11 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.1 Spain: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.2 Spain: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.3 Spain: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.4 Spain: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.11.5 Spain: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.2.12 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.1 Rest of Europe: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.2 Rest of Europe: Addiction Therapeutics Market, by Treatment Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.3 Rest of Europe: Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.4 Rest of Europe: Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.2.12.5 Rest of Europe: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.3 Asia Pacific: Addiction Therapeutics Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Addiction Therapeutics Market - Revenue and Forecast to 2031 (USD Million)
    • 11.3.3 Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.4 Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.5 Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
    • 11.3.6 Asia-Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.7 Asia Pacific: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.3.8 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.1 China: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.2 China Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.3 China Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.8.4 China Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.8.5 China: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.9 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.1 Japan: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.2 Japan Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.3 Japan Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.9.4 Japan Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.9.5 Japan: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.10 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.1 India: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.2 India Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.3 India Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.10.4 India Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.10.5 India: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.11 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.1 South Korea: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.2 South Korea Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.3 South Korea Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.11.4 South Korea Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.11.5 South Korea: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.12 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.1 Australia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.2 Australia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.3.12.3 Australia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.13 Australia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031 (USD Million)
      • 11.3.13.1 Australia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.3.14 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.3.14.1 Rest of Asia Pacific: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
    • 11.3.15 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.16 Rest of Asia Pacific Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.3.17 Rest of Asia Pacific Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.3.17.1 Rest of Asia Pacific: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.4 Middle East and Africa: Addiction Therapeutics Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Addiction Therapeutics Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.4.3 Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.4.4 Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.4.5 Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.5.1 Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.6 Middle East and Africa: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.4.7 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.1 Saudi Arabia: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.2 Saudi Arabia Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.3 Saudi Arabia Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.7.4 Saudi Arabia Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.7.5 Saudi Arabia: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.8 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.1 UAE: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.2 UAE Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.3 UAE Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.8.4 UAE Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.8.5 UAE: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.9 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.1 South Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.2 South Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.3 South Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.9.4 South Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.9.5 South Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.4.10 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.1 Rest of Middle East and Africa: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.2 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.3 Rest of Middle East and Africa Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.4.10.4 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.4.10.5 Rest of Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
  • 11.5 South and Central America: Addiction Therapeutics Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
    • 11.5.3 South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.5.4 South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
    • 11.5.5 South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.5.1 South and Central America: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.6 South and Central America: Addiction Therapeutics Market, by Country, 2024 and 2031 (%)
    • 11.5.7 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.1 Brazil: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.2 Brazil Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.3 Brazil Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.7.4 Brazil Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.7.5 Brazil: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.8 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.1 Argentina: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.2 Argentina Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.3 Argentina Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.8.4 Argentina Addiction Therapeutics Market, by Drug Type and Revenue and Forecast to 2031(USD Million)
      • 11.5.8.5 Argentina: Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031 (USD Million)
    • 11.5.9 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.1 Rest of South and Central America: Addiction Therapeutics Market and Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.2 Rest of South and Central America Addiction Therapeutics Market, by Treatment Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.3 Rest of South and Central America Addiction Therapeutics Market, by Drug Typeand Revenue and Forecast to 2031 (USD Million)
      • 11.5.9.4 Rest of South and Central America Addiction Therapeutics Market, by Treatment Center and Revenue and Forecast to 2031(USD Million)
      • 11.5.9.5 Rest of South and Central America Addiction Therapeutics Market, by Distribution Channel and Revenue and Forecast to 2031(USD Million)

12. Impact of COVID-19 Pandemic on Global Addiction Therapeutics Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Addictions Therapeutics Market and Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Indivior PLC
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Pfizer Inc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GlaxoSmithKline plc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Bausch Health Companies Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Cipla Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Orexo AB
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Purdue Pharma L.P.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Alvogen
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Camurus AB
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Hikma Pharmaceuticals PLC
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms